These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6111591)

  • 21. Effect of intracisternally administered adenosine and inosine on apomorphine- and amphetamine-induced stereotyped behaviour in rats.
    Singh J
    Indian J Physiol Pharmacol; 1990 Jan; 34(1):45-7. PubMed ID: 2361724
    [No Abstract]   [Full Text] [Related]  

  • 22. Possible noradrenergic involvement in naloxone potentiation of apomorphine-induced stereotypic climbing in mice.
    Quock RM; Bloom AS; Sadowski JA
    Pharmacol Biochem Behav; 1984 Nov; 21(5):733-6. PubMed ID: 6096896
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The morphogenesis of stereotyped behavior induced by the dopamine receptor agonist apomorphine in the laboratory rat.
    Szechtman H; Ornstein K; Teitelbaum P; Golani I
    Neuroscience; 1985 Mar; 14(3):783-98. PubMed ID: 2986045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modification of apomorphine-induced behaviour following chronic swim exercise in rats.
    Dey S; Singh RH
    Neuroreport; 1992 Jun; 3(6):497-500. PubMed ID: 1391756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stereotyped behaviour after cholinergic, but not dopaminergic, stimulation of the substantia nigra in rats.
    Decsi L; Nagy J; Zámbó K
    Life Sci; 1978 Jun; 22(21):1873-8. PubMed ID: 566832
    [No Abstract]   [Full Text] [Related]  

  • 26. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
    Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
    Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
    [No Abstract]   [Full Text] [Related]  

  • 27. Chronic intrastriatal dopamine infusions in rats with unilateral lesions of the substantia nigra.
    Hargraves R; Freed WJ
    Life Sci; 1987 Mar; 40(10):959-66. PubMed ID: 3821366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of nigro-striatal dopaminergic neurotransmission in the rat.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Neuropharmacology; 1977; 16(7-8):511-8. PubMed ID: 199852
    [No Abstract]   [Full Text] [Related]  

  • 29. Rotational behavior in dopamine nigrostriatal denervated rats: effects of a wide range of time intervals between apomorphine administrations.
    Casas M; Prat G; Robledo P; Jané F
    Pharmacol Biochem Behav; 1999 Mar; 62(3):481-5. PubMed ID: 10080240
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lesions of substantia nigra by kainic acid: effects on apomorphine-induced stereotyped behaviour.
    Morelli M; Porceddu ML; Di Chiara G
    Brain Res; 1980 Jun; 191(1):67-78. PubMed ID: 7189684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proceedings: The role of dopamine in rotational behaviour produced by unilateral lesions of the locus coeruleus.
    Donaldson I; Dolphin A; Jenner P; Mardsen CK; Pycock C
    Br J Pharmacol; 1975 Oct; 55(2):290P. PubMed ID: 119
    [No Abstract]   [Full Text] [Related]  

  • 32. Serotonin--dopamine interactions in the nigrostriatal system.
    Waldmeier PC; Delini-Stula AA
    Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel rotational behavior model for assessing the restructuring of striatal dopamine effector systems: are transplants sensitive to peripherally acting drugs?
    Norman AB; Calderon SF; Giordano M; Sanberg PR
    Prog Brain Res; 1988; 78():61-7. PubMed ID: 3247457
    [No Abstract]   [Full Text] [Related]  

  • 34. On the role of striatal and nonstriatal dopamine in opiate withdrawal.
    Herz A; Bläsig J; Laschka E; Gramsch C
    Adv Biochem Psychopharmacol; 1977; 16():597-9. PubMed ID: 560794
    [No Abstract]   [Full Text] [Related]  

  • 35. [Neurophysiologic and pharmacologic evidence of autoregulationin the nigrostriatal system].
    Arushanian EB; Tolpyshev BA
    Biull Eksp Biol Med; 1981 Feb; 91(2):133-6. PubMed ID: 7194700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Striatal cell supersensitivity to apomorphine in dopamine-lesioned rats correlated to behaviour.
    Schultz W; Ungerstedt U
    Neuropharmacology; 1978 Jun; 17(6):349-53. PubMed ID: 566861
    [No Abstract]   [Full Text] [Related]  

  • 37. The 6-hydroxydopamine rotational model for the detection of dopamine agonist activity: reliability of effect from different locations of 6-hydroxydopamine.
    Costall B; Naylor RJ; Pycock C
    J Pharm Pharmacol; 1975 Dec; 27(12):943-6. PubMed ID: 2668
    [No Abstract]   [Full Text] [Related]  

  • 38. Operant control of turning in circles: a new model of dopaminergic drug action.
    Glick SD
    Brain Res; 1982 Aug; 245(2):394-7. PubMed ID: 6889903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 40. Naloxone blockade of apomorphine-induced stereotyped behavior: interaction of endogenous opiates with dopamine.
    Margolin DI; Moon BH
    J Neurol Sci; 1979 Sep; 43(1):13-7. PubMed ID: 574897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.